Live attenuated Shigella sonnei vaccine (NIAID, WRSs2)
志贺菌减毒活疫苗（NIAID，WRSs2）
Report date: 2023/12/21 20:01:11
Base Information
Drug NameLive attenuated Shigella sonnei vaccine (NIAID, WRSs2)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Walter Reed Army Institute Of Research
China Registration ClassN/A
Develop Information
Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A